FDA warned website 247rxpill.in for selling unapproved opioid and benzodiazepine drugs to U.S. consumers.
What happened
FDA reviewed the website www.247rxpill.in and found it offering prescription opioid and benzodiazepine drugs for sale to U.S. consumers. The letter, dated August 31, 2021, says the site sold tramadol (shown as "Tramadol Hydrochloride 100 mg SR Tablets Radol-100") and clonazepam ("Rivotril" made by Galenika) without FDA-approved applications. FDA cited the opioid crisis and the risks of benzodiazepine misuse, and noted unapproved drugs may be contaminated, counterfeit, or contain different ingredients.
What FDA found
The site sold tramadol and clonazepam, which are new drugs with no FDA-approved application in effect for those versions.
Section 505(a) of the FD&C Act [21 U.S.C. § 355(a)]Offering these unapproved drugs for sale put them into interstate commerce illegally.
Section 301(d) of the FD&C Act [21 U.S.C. § 331(d)]The drug labeling does not give adequate directions for safe use by a layperson, and these prescription drugs cannot be safely self-diagnosed or self-treated.
Section 502(f)(1) of the FD&C Act [21 U.S.C. § 352(f)(1)]Because the drugs are unapproved, they do not get the exemption from adequate-directions labeling that approved drugs get.
21 CFR 201.115(a)Selling these misbranded drugs to U.S. consumers caused misbranded drugs to enter interstate commerce.
Section 301(a) of the FD&C Act [21 U.S.C. § 331(a)]
What FDA wants
FDA asked the company to stop offering the violating drugs for sale to U.S. consumers and to review its website, labels, and promotional materials for misleading or unapproved claims. The company must reply in writing within 15 working days describing steps taken and how it will prevent recurrence.
Who should pay attention
- online pharmacies shipping into the U.S.
- brands whose products appear on third-party websites
- regulatory teams that monitor internet drug sales
This is a summary. Read the original letter on fda.gov.